No Sweet-talk required: Medpro shareholders back Cipla buyout
This article was originally published in Scrip
Shareholders of South Africa's Cipla Medpro have approved its buyout by Indian partner, Cipla, putting to rest speculation around potential last mile hiccups in the deal amid reports that a prominent shareholder was keen on an improved offer.
You may also be interested in...
Aurobindo and Sandoz mutually terminate their planned $1bn deal, leaving many questions on how both sides will re-orient strategies going forward.
Takeda appoints new country head for India and aims to improve patient access to innovative medicines in the largely out-of-pocket market.
The coronavirus pandemic has thrown up unprecedented challenges for the Indian clinical trials segment, as in other parts of the world. Experts tell Scrip how things are poised in the country including potential impact on some critical milestones, but efforts are underway to tackle the crisis.